Orion Corporation: Managers’ transactions – Kari Jussi Aho
ORION CORPORATION MANAGERS’ TRANSACTIONS 5 MAY 2021 at 11.00 EEST Orion Corporation: Managers’ transactions – Kari…
Month: May 2021
Orion Corporation: Managers’ transactions – Hilpi Rautelin
ORION CORPORATION MANAGERS’ TRANSACTIONS 5 MAY 2021 at 11.00 EEST Orion Corporation: Managers’ transactions – Hilpi…
Orion Corporation: Managers’ transactions – Eija Ronkainen
ORION CORPORATION MANAGERS’ TRANSACTIONS 5 MAY 2021 at 11.00 EEST Orion Corporation: Managers’ transactions – Eija…
Zealand Pharma Hosts Conference Call on May 12 at 4 pm CET (10 am ET) to Present First Quarter Results for 2021
Company announcement – No. 27/ 2021 Zealand Pharma Hosts Conference Call on May 12 at…
Orion Corporation: Managers’ transactions – Mikael Silvennoinen
ORION CORPORATION MANAGERS’ TRANSACTIONS 5 MAY 2021 at 11.00 EEST Orion Corporation: Managers’ transactions – Mikael…
Orion Corporation: Managers’ transactions – Timo Maasilta
ORION CORPORATION MANAGERS’ TRANSACTIONS 5 MAY 2021 at 11.00 EEST Orion Corporation: Managers’ transactions – Timo…
Orion Corporation: Managers’ transactions – Ari Lehtoranta
ORION CORPORATION MANAGERS’ TRANSACTIONS 5 MAY 2021 at 11.00 EEST Orion Corporation: Managers’ transactions – Ari…
Orion Corporation: Managers’ transactions – Veli-Matti Mattila
ORION CORPORATION MANAGERS’ TRANSACTIONS 5 MAY 2021 at 11.00 EEST Orion Corporation: Managers’ transactions – Veli-Matti…
Tiziana Announces Strategic Initiative with Takanawa Japan K.K., Pharma Team, to Identify a Partner in Japan and Other Asian Countries for Further Clinical Development of Milciclib in Patients with Advanced Hepatocellular Carcinoma.
Objective of this partnership with Takanawa Japan K.K., Pharma Team, is to identify a strategic…
Novo Nordisk’s net profit increased by 6% in the first three months of 2021
Financial report for the period 1 January 2021 to 31 March 2021 Operating profit decreased…
Nicox partners with Laboratorios Grin to bring ZERVIATE to Mexico
Press Release Nicox partners with Laboratorios Grin to bring ZERVIATETM to Mexico May 5, 2021…
Roche’s Tecentriq approved by European Commission as a first-line monotherapy treatment for people with a type of metastatic non-small cell lung cancer
Tecentriq significantly improved overall survival in people with high PD-L1 expression, compared with chemotherapy in…
Addex Reports Q1 2021 Financial Results and Provides Corporate Update
Strong cash and cash equivalents position at March 31, 2021 of CHF25.2M ($26.7M) Completed $11.5M…
Valneva Announces an Indicative Price Range of its Previously Announced Proposed Global Offering
Saint-Herblain (France), May 5, 2021 – Valneva SE (the “Company”), a specialty vaccine company focused…
Supernus Announces Paragraph IV ANDA Filing for XADAGO®
ROCKVILLE, Md., May 04, 2021 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical…
Aquestive Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
On track to refile Libervant™ (diazepam) Buccal Film New Drug Application (NDA) by end of…
Cocrystal Pharma Announces $40 Million Bought Deal Offering of Common Stock
BOTHELL, Wash., May 04, 2021 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a…
Certara Launches Secondary Intelligence™ Software to Predict Risk of Unwanted Side Effects of Drug Candidates Earlier
First-of-its-kind software predicts likelihood of off-target safety issues that could impede clinical progress PRINCETON, N.J.,…
Lowell Farms Inc. Announces First Quarter 2021 Financial Results
Vertically-integrated cannabis leader finishes quarter with multiple post-merger successes and strong position for future expansion…
Vaccitech Announces Closing of $110.5 Million Initial Public Offering
OXFORD, United Kingdom, May 04, 2021 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC), a clinical-stage…